Breast Cancer — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — CDK4/6 inhibitor-related hepatotoxicity
CDK4/6 inhibitor hepatotoxicity (most common with abemaciclib). Isolated transaminase rise without imaging progression suggests drug-related toxicity. Hold and dose reduce.
Reference: BNF CDK4/6 inhibitor monographs; ESMO 2024 MBC Guidelines